These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Optic radiation involvement in optic pathway gliomas in neurofibromatosis. Liu GT; Brodsky MC; Phillips PC; Belasco J; Janss A; Golden JC; Bilaniuk LL; Burson GT; Duhaime AC; Sutton LN Am J Ophthalmol; 2004 Mar; 137(3):407-14. PubMed ID: 15013861 [TBL] [Abstract][Full Text] [Related]
3. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening. Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105 [TBL] [Abstract][Full Text] [Related]
4. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859 [TBL] [Abstract][Full Text] [Related]
5. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. Balcer LJ; Liu GT; Heller G; Bilaniuk L; Volpe NJ; Galetta SL; Molloy PT; Phillips PC; Janss AJ; Vaughn S; Maguire MG Am J Ophthalmol; 2001 Apr; 131(4):442-5. PubMed ID: 11292406 [TBL] [Abstract][Full Text] [Related]
6. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Listernick R; Ferner RE; Liu GT; Gutmann DH Ann Neurol; 2007 Mar; 61(3):189-98. PubMed ID: 17387725 [TBL] [Abstract][Full Text] [Related]
7. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials. Chang BC; Mirabella G; Yagev R; Banh M; Mezer E; Parkin PC; Westall CA; Buncic JR Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2895-902. PubMed ID: 17525226 [TBL] [Abstract][Full Text] [Related]
8. Management options for visual pathway compression from optic gliomas. Bessero AC; Fraser C; Acheson J; Davagnanam I Postgrad Med J; 2013 Jan; 89(1047):47-51. PubMed ID: 23001214 [TBL] [Abstract][Full Text] [Related]
9. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature. Friedrich RE; Nuding MA Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519 [TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Thiagalingam S; Flaherty M; Billson F; North K Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338 [TBL] [Abstract][Full Text] [Related]
14. Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision. de Blank PMK; Fisher MJ; Liu GT; Gutmann DH; Listernick R; Ferner RE; Avery RA J Neuroophthalmol; 2017 Sep; 37 Suppl 1(Suppl 1):S23-S32. PubMed ID: 28806346 [TBL] [Abstract][Full Text] [Related]
15. Optic Gliomas in Neurofibromatosis Type 1. Parkhurst E; Abboy S J Pediatr Ophthalmol Strabismus; 2016 Nov; 53(6):334-338. PubMed ID: 27537249 [TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis 1-associated optic pathway gliomas. Shofty B; Ben Sira L; Constantini S Childs Nerv Syst; 2020 Oct; 36(10):2351-2361. PubMed ID: 32524182 [TBL] [Abstract][Full Text] [Related]
17. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1. Wan MJ; Ullrich NJ; Manley PE; Kieran MW; Goumnerova LC; Heidary G J Neurooncol; 2016 Aug; 129(1):173-8. PubMed ID: 27311725 [TBL] [Abstract][Full Text] [Related]
18. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis]. Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799 [TBL] [Abstract][Full Text] [Related]
19. Utility of optic pathway glioma screening in young children with neurofibromatosis type I: questions generated by a clinical audit. Pilling RF; Lloyd IC; Huson S Eye (Lond); 2010 Oct; 24(10):1603-5. PubMed ID: 20689568 [TBL] [Abstract][Full Text] [Related]